Cargando…
Molecular Analyses of Clinical Isolates and Recombinant SARS-CoV-2 Carrying B.1 and B.1.617.2 Spike Mutations Suggest a Potential Role of Non-Spike Mutations in Infection Kinetics
Some of the emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants are less susceptible to neutralization with post-vaccine sera and monoclonal antibodies targeting the viral spike glycoprotein. This raises concerns of disease control, transmissibility, and severity. Numerous...
Autores principales: | Veleanu, Andrei, Kelch, Maximilian A., Ye, Chengjin, Flohr, Melanie, Wilhelm, Alexander, Widera, Marek, Martinez-Sobrido, Luis, Ciesek, Sandra, Toptan, Tuna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506066/ https://www.ncbi.nlm.nih.gov/pubmed/36146823 http://dx.doi.org/10.3390/v14092017 |
Ejemplares similares
-
Structural Evolution of Delta (B.1.617.2) and Omicron (BA.1) Spike Glycoproteins
por: Prandi, Ingrid Guarnetti, et al.
Publicado: (2022) -
The SARS-CoV-2 Delta (B.1.617.2) variant with spike N501Y mutation in the shadow of Omicron emergence
por: Salimović-Bešić, Irma, et al.
Publicado: (2022) -
Antibody-Mediated Neutralization of Authentic SARS-CoV-2 B.1.617 Variants Harboring L452R and T478K/E484Q
por: Wilhelm, Alexander, et al.
Publicado: (2021) -
SARS-CoV-2 Delta (B.1.617.2) Variant: A Unique T478K Mutation in Receptor Binding Motif (RBM) of Spike Gene
por: Jhun, Hyunjhung, et al.
Publicado: (2021) -
Genetic emergence of B.1.617.2 in COVID-19
por: Kirola, L.
Publicado: (2021)